Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine and Pregabalin for Gulf War Illness
NCT01846182Phase 2Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Jun 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duloxetine, pregabalin in Gulf War illness (GWI), sponsored by VA Office of Research & Development. Started Jun 2015; status: terminated.
02
Drugs
duloxetinepregabalin
03
Conditions
Gulf War illness (GWI)
Beyond the preview
Go deeper on NCT01846182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01846182.